Efficacy of RGn600 in Patients With Mild-to-moderate Alzheimer's Disease
NCT: NCT05926011 · RECRUITING
Brief Summary
This is a controlled investigation, with randomization of the patients, which aims at demonstrating the efficacy of device RGn600 in treating patients with mild-to-moderate Alzheimer's disease (AD). RGn600 is a non-invasive medical device which is applied on the head (helmet) and on the abdomen (abdominal belt). It combines 2 technologies: * PhotoBioModulation (PBM), which involves exposure to light from the red to near-infrared wavelengths using lasers and Light Emitting Diodes (LEDs) * Static Magnetic Stimulation (SMS), which consists in the application of a static magnetic field. Considering previous investigations, this innovative technology could reduce inflammation on the brain-gut axis, implicated in the development of Alzheimer's disease.
Frequently Asked Questions
What is Efficacy of RGn600 in Patients With Mild-to-moderate Alzheimer's Disease?
Efficacy of RGn600 in Patients With Mild-to-moderate Alzheimer's Disease is a clinical trial registered under NCT05926011. Current status: RECRUITING.
What is the status of NCT05926011?
The current status of NCT05926011 (Efficacy of RGn600 in Patients With Mild-to-moderate Alzheimer's Disease) is: RECRUITING.
When did Efficacy of RGn600 in Patients With Mild-to-moderate Alzheimer's Disease start?
Efficacy of RGn600 in Patients With Mild-to-moderate Alzheimer's Disease started on 2023-07-24.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.